| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Lipid Research, Vol 30, 305-315, Copyright © 1989 by Lipid Research, Inc.
ARTICLES |
UP Steinbrecher and PH Pritchard
Department of Medicine, University of British Columbia, Vancouver, Canada.
Degradation of phosphatidylcholine to lysophosphatidylcholine occurs during oxidative modification of low density lipoproteins (LDL). In this study, we have shown that this phospholipid hydrolysis is brought about by an LDL-associated phospholipase A2 that can hydrolyze oxidized but not intact LDL phosphatidylcholine. The chemical nature of the oxidized phospholipids that can act as substrates for this enzyme was not fully characterized, but we hypothesized that the specificity of the enzyme for oxidized LDL phosphatidylcholine might be explained by fragmentation of polyunsaturated sn-2 fatty acyl groups in LDL phosphatidylcholine during oxidation. To facilitate characterization of this enzyme, we therefore selected a fluorescent phosphatidylcholine substrate that had a short-chain, polar residue in the sn-2 position: 1- palmitoyl 2-(6-[7-nitrobenzoxadiazolyl]amino) caproyl phosphatidylcholine, (C6NBD PC). This substrate was efficiently hydrolyzed by LDL, but the dodecanoyl analogue of C6NBD PC, which differed only in that a 12-carbon rather than a 6-carbon acyl derivative was present in the sn-2 position, was not hydrolyzed. The phospholipase activity was heat-stable, calcium-independent, and was inhibited by the serine esterase inhibitors phenylmethylsulfonyl- fluoride and diisopropylfluorophosphate, but was resistant to p- bromophenacylbromide and dithiobisnitrobenzoic acid. The phospholipid hydrolysis could not be attributed to the action of lecithin:cholesterol acyltransferase or lipoprotein lipase. Nearly all of the activity in EDTA-anticoagulated normal plasma was physically associated with apoB-containing lipoproteins, but this apoprotein was not essential as enzyme activity was present in plasma from abetalipoproteinemic patients. These properties are very similar to those recently reported for human plasma platelet-activating factor (PAF) acetylhydrolase. In the present study, we found that acylhydrolase activity against C6NBD PC, PAF, and oxidized phosphatidylcholine copurfied through gel filtration and ion-exchange chromatography. Substrate competition was demonstrated between C6NBD PC, PAF, and oxidized 2-arachidonyl phosphatidylcholine, suggesting that a single enzyme was active against all three substrates. The enzyme had an apparent molecular weight of 40,000-45,000 by high pressure gel exclusion chromatography. Inhibition of this activity with disopropyfluorophosphate prior to oxidative modification of LDL prevented phospholipid hydrolysis but did not affect the production of thiobarbituric acid reactive compounds or the change in electrophoretic mobility. In addition, this inhibition of phospholipase did not prevent the rapid degradati
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. H. Han, K. H. Hong, J. Ko, K. S. Rhee, M. K. Hong, J. J. Kim, Y. H. Kim, and S. J. Park Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells J. Leukoc. Biol., July 1, 2004; 76(1): 195 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Coutant, S. Agaugue, L. Perrin-Cocon, P. Andre, and V. Lotteau Sensing Environmental Lipids by Dendritic Cell Modulates Its Function J. Immunol., January 1, 2004; 172(1): 54 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kujiraoka, T. Iwasaki, M. Ishihara, M. Ito, M. Nagano, A. Kawaguchi, S. Takahashi, J. Ishi, M. Tsuji, T. Egashira, et al. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus J. Lipid Res., October 1, 2003; 44(10): 2006 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Coutant, L. Perrin-Cocon, S. Agaugue, T. Delair, P. Andre, and V. Lotteau Mature Dendritic Cell Generation Promoted by Lysophosphatidylcholine J. Immunol., August 15, 2002; 169(4): 1688 - 1695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Tselepis, S.-A. P. Karabina, D. Stengel, R. Piedagnel, M. J. Chapman, and E. Ninio N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL J. Lipid Res., October 1, 2001; 42(10): 1645 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Marathe, A. R. Silva, H. C. de Castro Faria Neto, L. W. Tjoelker, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids J. Lipid Res., September 1, 2001; 42(9): 1430 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Quarck, B. De Geest, D. Stengel, A. Mertens, M. Lox, G. Theilmeier, C. Michiels, M. Raes, H. Bult, D. Collen, et al. Adenovirus-Mediated Gene Transfer of Human Platelet-Activating Factor-Acetylhydrolase Prevents Injury-Induced Neointima Formation and Reduces Spontaneous Atherosclerosis in Apolipoprotein E-Deficient Mice Circulation, May 22, 2001; 103(20): 2495 - 2500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Van Lenten, A. C. Wagner, D. P. Nayak, S. Hama, M. Navab, and A. M. Fogelman High-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A Infection Circulation, May 8, 2001; 103(18): 2283 - 2288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Roland, R. A. Patterson, and D. S. Leake Measurement of Copper-Binding Sites on Low Density Lipoprotein Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 594 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kawamura, J. W. Heinecke, and A. Chait Increased uptake of {alpha}-hydroxy aldehyde-modified low density lipoprotein by macrophage scavenger receptors J. Lipid Res., July 1, 2000; 41(7): 1054 - 1059. [Abstract] [Full Text]
|
|
|
|
|
|
R. A. Memon, I. Staprans, M. Noor, W. M. Holleran, Y. Uchida, A. H. Moser, K. R. Feingold, and C. Grunfeld Infection and Inflammation Induce LDL Oxidation In Vivo Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1536 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gomez-Munoz, J. S. Martens, and U. P. Steinbrecher Stimulation of Phospholipase D Activity by Oxidized LDL in Mouse Peritoneal Macrophages Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 135 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. I. Kitsiouli, G. Nakos, and M. E. Lekka Differential determination of phospholipase A2 and PAF-acetylhydrolase in biological fluids using fluorescent substrates J. Lipid Res., December 1, 1999; 40(12): 2346 - 2356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hakkinen, J. S. Luoma, M. O. Hiltunen, C. H. Macphee, K. J. Milliner, L. Patel, S. Q. Rice, D. G. Tew, K. Karkola, and S. Yla-Herttuala Lipoprotein-Associated Phospholipase A2, Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2909 - 2917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Gowri, D. R. Van der Westhuyzen, S. R. Bridges, and J. W. Anderson Decreased Protection by HDL From Poorly Controlled Type 2 Diabetic Subjects Against LDL Oxidation May Be Due to the Abnormal Composition of HDL Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2226 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Salomon, W. Sha, C. Brame, K. Kaur, G. Subbanagounder, J. O'Neil, H. F. Hoff, and L. J. Roberts II Protein Adducts of Iso[4]levuglandin E2, a Product of the Isoprostane Pathway, in Oxidized Low Density Lipoprotein J. Biol. Chem., July 16, 1999; 274(29): 20271 - 20280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Memon, J. Fuller, A. H. Moser, K. R. Feingold, and C. Grunfeld In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1999; 277(1): R94 - R103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Martens, M. Lougheed, A. Gomez-Munoz, and U. P. Steinbrecher A Modification of Apolipoprotein B Accounts for Most of the Induction of Macrophage Growth by Oxidized Low Density Lipoprotein J. Biol. Chem., April 16, 1999; 274(16): 10903 - 10910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Tsoukatos, M. Arborati, T. Liapikos, K. L. Clay, R. C. Murphy, M. J. Chapman, and E. Ninio Copper-Catalyzed Oxidation Mediates PAF Formation in Human LDL Subspecies : Protective Role of PAF:Acetylhydrolase in Dense LDL Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3505 - 3512. [Abstract] [Full Text]
|
|
|
|
|
|
J. Goyal, K. Wang, M. Liu, and P. V. Subbaiah Novel Function of Lecithin-Cholesterol Acyltransferase. HYDROLYSIS OF OXIDIZED POLAR PHOSPHOLIPIDS GENERATED DURING LIPOPROTEIN OXIDATION J. Biol. Chem., June 27, 1997; 272(26): 16231 - 16239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Itabe, H. Yamamoto, M. Suzuki, Y. Kawai, Y. Nakagawa, A. Suzuki, T. Imanaka, and T. Takano Oxidized Phosphatidylcholines That Modify Proteins. ANALYSIS BY MONOCLONAL ANTIBODY AGAINST OXIDIZED LOW DENSITY LIPOPROTEIN J. Biol. Chem., December 27, 1996; 271(52): 33208 - 33217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hattori, H. Adachi, A. Matsuzawa, K. Yamamoto, M. Tsujimoto, J. Aoki, M. Hattori, H. Arai, and K. Inoue cDNA Cloning and Expression of Intracellular Platelet-activating Factor (PAF) Acetylhydrolase II. ITS HOMOLOGY WITH PLASMA PAF ACETYLHYDROLASE J. Biol. Chem., December 20, 1996; 271(51): 33032 - 33038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Tselepis, C. Dentan, S.-A. P. Karabina, M. J. Chapman, and E. Ninio PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human Plasma : Catalytic Characteristics and Relation to the Monocyte-Derived Enzyme Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1764 - 1773. [Abstract] [Full Text]
|
|
|
|
|
|
K. Hattori, M. Hattori, H. Adachi, M. Tsujimoto, H. Arai, and K. Inoue Purification and Characterization of Platelet-activating Factor Acetylhydrolase II from Bovine Liver Cytosol J. Biol. Chem., September 22, 1995; 270(38): 22308 - 22313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Ahmed, A. Ravandi, G. F. Maguire, A. Emili, D. Draganov, B. N. L. Du, A. Kuksis, and P. W. Connelly Apolipoprotein A-I Promotes the Formation of Phosphatidylcholine Core Aldehydes That Are Hydrolyzed by Paraoxonase (PON-1) during High Density Lipoprotein Oxidation with a Peroxynitrite Donor J. Biol. Chem., June 29, 2001; 276(27): 24473 - 24481. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
